Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Humphreys

Showing results (441-450 of 450) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 450 results.
Nature Genetics|March 2, 2016
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170Alison M Dunning, Kyriaki Michailidou, Karoline B Kuchenbaecker, et al.
Genetic Epidemiology|March 3, 2020
Transcriptome-wide association study of breast cancer risk by estrogen-receptor statusHelian Feng, Alexander Gusev, Bogdan Pasaniuc, et al.
Nature Genetics|March 10, 2015
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerKyriaki Michailidou, Jonathan Beesley, Sara Lindstrom, et al.
Nature Communications|April 28, 2016
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancerFergus J Couch, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
American Journal of Human Genetics|December 18, 2018
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesNasim Mavaddat, Kyriaki Michailidou, Joe Dennis, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Nature|October 24, 2017
Association analysis identifies 65 new breast cancer risk lociKyriaki Michailidou, Sara Lindström, Joe Dennis, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 29, 2013
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerStig E Bojesen, Karen A Pooley, Sharon E Johnatty, et al.
Nature Genetics|October 24, 2017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerRoger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
Pageof 45

Showing results (441-450 of 450) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 450 results.
Nature Genetics|March 2, 2016
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170Alison M Dunning, Kyriaki Michailidou, Karoline B Kuchenbaecker, et al.
Genetic Epidemiology|March 3, 2020
Transcriptome-wide association study of breast cancer risk by estrogen-receptor statusHelian Feng, Alexander Gusev, Bogdan Pasaniuc, et al.
Nature Genetics|March 10, 2015
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerKyriaki Michailidou, Jonathan Beesley, Sara Lindstrom, et al.
Nature Communications|April 28, 2016
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancerFergus J Couch, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
American Journal of Human Genetics|December 18, 2018
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer SubtypesNasim Mavaddat, Kyriaki Michailidou, Joe Dennis, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Nature|October 24, 2017
Association analysis identifies 65 new breast cancer risk lociKyriaki Michailidou, Sara Lindström, Joe Dennis, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 29, 2013
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancerStig E Bojesen, Karen A Pooley, Sharon E Johnatty, et al.
Nature Genetics|October 24, 2017
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancerRoger L Milne, Karoline B Kuchenbaecker, Kyriaki Michailidou, et al.
Pageof 45